Today, Congressman Bob Latta (R-Bowling Green) issued the following statement after he voted for the Food and Drug Administration Reform Act, H.R. 5651.
"This important legislation will reauthorize user fee programs for prescription drugs and medical devices, establish user fee programs for generic drugs and biosimilars, as well as reform Food and Drug Administration (FDA) programs. This legislation also includes reforms to ensure patients receive quality care and timely access to new therapies while promoting innovation and job creation."
Congressman Latta collaborated with colleagues to insert language in the bill draft that assists hospital systems in coping with drug shortages by allowing them to repackage those drugs into smaller doses. Rep. Latta worked closely with the Cleveland Clinic and other hospital systems around the country on the issue. Current law does not allow for a hospital to repackage a drug for use in another hospital within their system.
"I am very pleased this repackaging language was included in the final bill to help address drug shortages. I will work to ensure this language is included in the final Conference Committee report," Latta said.